SECUREOURMEDS.ORG KEYWORD DENSITY CHECKER

Total words: 2229 | 2-word phrases: 577 | 3-word phrases: 639 | 4-word phrases: 661

PAGE INFO

Title Try to keep the title under 60 characters (33 characters)
Secure Our Meds - Secure Our Meds
Description Try to keep the meta description between 50 - 160 characters (73 characters)
Secure patient access to medications no matter what challenges may arise.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (15 characters)
Secure Our Meds

ONE WORD PHRASES 352 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the308.52%
2and267.39%
3to246.82%
4secure185.11%
5of133.69%
6generic123.41%
7medicines113.13%
8supply113.13%
9our113.13%
10chain82.27%

TWO WORD PHRASES 577 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1secure our101.73%
2and biosimilar81.39%
3supply chain71.21%
4in the61.04%
5generic and61.04%
6our meds40.69%
7and a40.69%
8biosimilars industry40.69%
9patient access40.69%
10and biosimilars40.69%
11the us40.69%
12to a30.52%
13generic medicine30.52%
14generics and30.52%
15secure supply30.52%
16our access30.52%
17secure markets20.35%
18we can20.35%
19on generic20.35%
20to secure20.35%

THREE WORD PHRASES 639 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1generic and biosimilar60.94%
2secure our meds40.63%
3secure our access30.47%
4and biosimilars industry30.47%
5global supply chain20.31%
6the united states20.31%
7generic and biosimilars20.31%
8in the us20.31%
9on biosimilars to20.31%
10patient access no20.31%
11safe and reliable20.31%
12these safe and20.31%
13generic or biosimilar20.31%
14biosimilars to help20.31%
15share your story20.31%
16our meds secure20.31%
17generics and biosimilars20.31%
18secure supply chain20.31%
19for these medicines20.31%
20secure our markets20.31%
21meds secure our20.31%
22costsharing formulary tiers10.16%
23formulary tiers ensuring10.16%
24tiers ensuring new10.16%
25ensuring new generics10.16%
26on lower costsharing10.16%
27are covered and10.16%
28covered and available10.16%
29and available to10.16%
30available to seniors10.16%

FOUR WORD PHRASES 661 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1generic and biosimilars industry20.30%
2these safe and reliable20.30%
3on biosimilars to help20.30%
4to include priority generic10.15%
5stockpile to include priority10.15%
6national stockpile to include10.15%
7penalty expanding the strategic10.15%
8generics penalty expanding the10.15%
9medicines policies to achieve10.15%
10medicaid generics penalty expanding10.15%
11the medicaid generics penalty10.15%
12include priority generic medicines10.15%
13repealing the medicaid generics10.15%
14achieve that goal include10.15%
15to achieve that goal10.15%
16policies to achieve that10.15%
17top secure our meds10.15%
18for these medicines policies10.15%
19these medicines policies to10.15%
20generics on lower costsharing10.15%
21marketplace for these medicines10.15%
22economics and a healthy10.15%
23sound economics and a10.15%
24of sound economics and10.15%
25necessity of sound economics10.15%
26the necessity of sound10.15%
27reinforces the necessity of10.15%
28pandemic reinforces the necessity10.15%
29similar promise the global10.15%
30shows similar promise the10.15%
31industry shows similar promise10.15%
32biosimilars industry shows similar10.15%
33nascent biosimilars industry shows10.15%
34priority generic medicines placing10.15%
35lower costsharing formulary tiers10.15%
36on lower costsharing formulary10.15%
37plans for coverage of10.15%
38stopping the “most favored10.15%
39traps stopping the “most10.15%
40rebate traps stopping the10.15%

EXTERNAL LINKS

# URL Whois Check
1https://accessiblemeds.org/advocacy/medicaid-generics-penalty Whoisaccessiblemeds.org
2 https://accessiblemeds.org/blueprint Whoisaccessiblemeds.org
3 https://accessiblemeds.org/resources/reports/white-paper-access-denied-first-generics Whoisaccessiblemeds.org
4 https://accessiblemeds.org/resources/press-releases/aam-statement-trump-administration-most-favored-nation-model Whoisaccessiblemeds.org
5 https://accessiblemeds.org/resources/reports/2021-savings-report Whoisaccessiblemeds.org
6 https://accessiblemeds.org/resources/reports/AAM-white-paper-seniors-sidelined-generic-substitution Whoisaccessiblemeds.org
7 https://accessiblemeds.org/resources/reports/medicare-part-d-generic-tiering Whoisaccessiblemeds.org
8 https://accessiblemeds.org/access-denied Whoisaccessiblemeds.org
9 https://accessiblemeds.org/resources/reports/white-paper-part-2-failure-launch-barriers-biosimilar-market-adoption Whoisaccessiblemeds.org
10 https://accessiblemeds.org/resources/reports/white-paper-medicare-and-commercial-plans-fail-get-new-generics-patients Whoisaccessiblemeds.org
11 https://biosimilarscouncil.org/resource/failure-to-launch-white-paper/ Whoisbiosimilarscouncil.org
12 https://accessiblemeds.org/resources/reports/unintended-economics-blocking-act Whoisaccessiblemeds.org
13 https://accessiblemeds.org/share-your-story Whoisaccessiblemeds.org
14 https://youtu.be/r1waCm2bglU Whoisyoutu.be
15 https://youtu.be/afUA_rYt2nY Whoisyoutu.be
16 https://youtu.be/e1Snzu3YsY8 Whoisyoutu.be
17 https://youtu.be/zWbYFNSOtpw Whoisyoutu.be
18 https://www.accessiblemeds.org/ Whoisaccessiblemeds.org
19 https://accessiblemeds.org/privacy-policy Whoisaccessiblemeds.org
20 https://accessiblemeds.org/aam-terms-use Whoisaccessiblemeds.org